Emma A. Mol

2.3k total citations · 1 hit paper
14 papers, 1.8k citations indexed

About

Emma A. Mol is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Emma A. Mol has authored 14 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Surgery and 7 papers in Cancer Research. Recurrent topics in Emma A. Mol's work include Extracellular vesicles in disease (11 papers), MicroRNA in disease regulation (7 papers) and Tissue Engineering and Regenerative Medicine (6 papers). Emma A. Mol is often cited by papers focused on Extracellular vesicles in disease (11 papers), MicroRNA in disease regulation (7 papers) and Tissue Engineering and Regenerative Medicine (6 papers). Emma A. Mol collaborates with scholars based in Netherlands, United States and Sweden. Emma A. Mol's co-authors include Pieter Vader, Raymond M. Schiffelers, Gerard Pasterkamp, Joost P. G. Sluijter, Marie‐José Goumans, Pieter A. Doevendans, Janine C. Deddens, Anke M. Smits, Janita A. Maring and Kirsten Lodder and has published in prestigious journals such as PLoS ONE, Advanced Drug Delivery Reviews and Cardiovascular Research.

In The Last Decade

Emma A. Mol

14 papers receiving 1.8k citations

Hit Papers

Extracellular vesicles for drug delivery 2016 2026 2019 2022 2016 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Extracellular vesicles for drug delivery
    2016 979 citations Pieter Vader, Emma A. Mol et al. Advanced Drug Delivery Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emma A. Mol Netherlands 12 1.6k 784 336 207 194 14 1.8k
Li Qiao China 15 913 0.6× 471 0.6× 330 1.0× 274 1.3× 320 1.6× 41 1.6k
Elisa Lázaro‐Ibáñez Finland 19 2.2k 1.4× 1.2k 1.5× 394 1.2× 105 0.5× 76 0.4× 24 2.4k
Tyler A. Allen United States 14 834 0.5× 389 0.5× 361 1.1× 286 1.4× 319 1.6× 22 1.4k
Helena Sork Estonia 12 1.6k 1.0× 811 1.0× 204 0.6× 80 0.4× 97 0.5× 14 1.7k
Giulia Corso Sweden 10 1.8k 1.1× 997 1.3× 240 0.7× 74 0.4× 87 0.4× 11 1.9k
Ylva Gustafsson Sweden 4 1.2k 0.8× 696 0.9× 200 0.6× 101 0.5× 121 0.6× 6 1.4k
Sander A. A. Kooijmans Netherlands 19 3.0k 1.9× 1.6k 2.0× 576 1.7× 276 1.3× 108 0.6× 31 3.3k
Phuong‐Uyen Dinh United States 20 1.7k 1.1× 634 0.8× 514 1.5× 413 2.0× 428 2.2× 28 2.6k
Sara Busatto United States 20 1.5k 1.0× 798 1.0× 354 1.1× 132 0.6× 51 0.3× 28 1.7k
Jarmo Käpylä Finland 24 771 0.5× 329 0.4× 227 0.7× 364 1.8× 115 0.6× 48 2.0k

Countries citing papers authored by Emma A. Mol

Since Specialization
Citations

This map shows the geographic impact of Emma A. Mol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma A. Mol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma A. Mol more than expected).

Fields of papers citing papers by Emma A. Mol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma A. Mol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma A. Mol. The network helps show where Emma A. Mol may publish in the future.

Co-authorship network of co-authors of Emma A. Mol

This figure shows the co-authorship network connecting the top 25 collaborators of Emma A. Mol. A scholar is included among the top collaborators of Emma A. Mol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma A. Mol. Emma A. Mol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Roefs, Marieke T., Julia Bauzá‐Martinez, Simonides Immanuel van de Wakker, et al.. (2023). Cardiac progenitor cell-derived extracellular vesicles promote angiogenesis through both associated- and co-isolated proteins. Communications Biology. 6(1). 800–800. 20 indexed citations
2.
Wakker, Simonides Immanuel van de, Emma A. Mol, Marieke T. Roefs, et al.. (2021). Influence of short term storage conditions, concentration methods and excipients on extracellular vesicle recovery and function. European Journal of Pharmaceutics and Biopharmaceutics. 170. 59–69. 43 indexed citations
3.
Mol, Emma A., Zhiyong Lei, Marieke T. Roefs, et al.. (2019). Injectable Supramolecular Ureidopyrimidinone Hydrogels Provide Sustained Release of Extracellular Vesicle Therapeutics. Advanced Healthcare Materials. 8(20). e1900847–e1900847. 82 indexed citations
4.
Deddens, Janine C., Emma A. Mol, Linda W. van Laake, et al.. (2019). Anti-fibrotic Effects of Cardiac Progenitor Cells in a 3D-Model of Human Cardiac Fibrosis. Frontiers in Cardiovascular Medicine. 6. 52–52. 28 indexed citations
5.
Hoogen, Patricia van den, Saskia C.A. de Jager, Emma A. Mol, et al.. (2019). Potential of mesenchymal- and cardiac progenitor cells for therapeutic targeting of B-cells and antibody responses in end-stage heart failure. PLoS ONE. 14(12). e0227283–e0227283. 12 indexed citations
6.
Lei, Zhiyong, Emma A. Mol, Linglei Jiang, et al.. (2019). Biofabrication of Cell-Derived Nanovesicles: A Potential Alternative to Extracellular Vesicles for Regenerative Medicine. Cells. 8(12). 1509–1509. 50 indexed citations
7.
Maring, Janita A., Kirsten Lodder, Emma A. Mol, et al.. (2018). Cardiac Progenitor Cell–Derived Extracellular Vesicles Reduce Infarct Size and Associate with Increased Cardiovascular Cell Proliferation. Journal of Cardiovascular Translational Research. 12(1). 5–17. 53 indexed citations
8.
Mol, Emma A., Zhiyong Lei, Maarten Bakker, et al.. (2018). 202Slow release of cardiac progenitor cell-derived extracellular vesicles from a pH-switchable hydrogel. Cardiovascular Research. 114(suppl_1). S53–S53. 1 indexed citations
9.
Gaetani, Roberto, Eva van Ingen, Emma A. Mol, et al.. (2018). Decellularized Extracellular Matrix Hydrogels as a Delivery Platform for MicroRNA and Extracellular Vesicle Therapeutics. Advanced Therapeutics. 1(3). 41 indexed citations
10.
Mol, Emma A., Marie‐José Goumans, & Joost P. G. Sluijter. (2017). Cardiac Progenitor-Cell Derived Exosomes as Cell-Free Therapeutic for Cardiac Repair. Advances in experimental medicine and biology. 998. 207–219. 22 indexed citations
11.
Janssen, Paul W.A., et al.. (2017). Does percutaneous coronary stent implantation increase platelet reactivity?. Blood Reviews. 31(5). 271–275. 5 indexed citations
12.
Mol, Emma A., Marie‐José Goumans, Pieter A. Doevendans, Joost P. G. Sluijter, & Pieter Vader. (2017). Higher functionality of extracellular vesicles isolated using size-exclusion chromatography compared to ultracentrifugation. Nanomedicine Nanotechnology Biology and Medicine. 13(6). 2061–2065. 305 indexed citations
13.
Vader, Pieter, Emma A. Mol, Gerard Pasterkamp, & Raymond M. Schiffelers. (2016). Extracellular vesicles for drug delivery. Advanced Drug Delivery Reviews. 106(Pt A). 148–156. 979 indexed citations breakdown →
14.
Vrijsen, Krijn R., Janita A. Maring, Steven A. J. Chamuleau, et al.. (2016). Exosomes from Cardiomyocyte Progenitor Cells and Mesenchymal Stem Cells Stimulate Angiogenesis Via EMMPRIN. Advanced Healthcare Materials. 5(19). 2555–2565. 162 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Li Qiao Breakdown of academic impact, for papers by Elisa Lázaro‐Ibáñez Breakdown of academic impact, for papers by Tyler A. Allen Breakdown of academic impact, for papers by Helena Sork Breakdown of academic impact, for papers by Giulia Corso Breakdown of academic impact, for papers by Ylva Gustafsson Breakdown of academic impact, for papers by Sander A. A. Kooijmans Breakdown of academic impact, for papers by Phuong‐Uyen Dinh Breakdown of academic impact, for papers by Sara Busatto Breakdown of academic impact, for papers by Jarmo Käpylä
Rankless by CCL
2026